The importance of utilization management within the medical benefit
The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.
Read MoreClinically Speaking: Gene Therapies: Million-Dollar Miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read MoreCarepathRx Health System Solutions and Evernorth Health Services Forge Strategic Partnership to Enhance Specialty Care for Patients
The partnership between CarepathRx Health System Solutions and Evernorth brings together diverse specialty and care expertise to improve, expand, and accelerate pharmacy care delivery for the growing ...
Read MoreWhat to look for in the upcoming gene therapy pipeline
As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.
Read MoreExpress Scripts Further Advances Transparency and Affordability for Consumers and Clients
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...
Read MoreThe Pharmacy Benefit Management Team: Helping Patients Access Affordable Prescription Drugs Safely and Efficiently
Pharmacy benefit managers (PBMs) like Express Scripts are uniquely positioned to help patients in numerous ways.
Read MoreStrategies to Encourage the Adoption of Biosimilars
Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.
Read MoreSimplifying medical benefit drug management complexities
An integrated approach to managing medically billed specialty drugs is key to optimizing cost savings and clinical outcomes.
Read More